Alpha Tau Medical Ltd. — financial figures as filed

DRTS · CIK 1871321 · 8 fiscal years on record

Every figure below is taken from a filed report through an explicit tag map and carries the tag and accession number it came from. A metric the company did not disclose is shown as , never as zero.

Aggregates

computed from the figures below
Metrics filled
10 / 12
canonical metrics mapped from the filings
Mapping completeness
83.3%
2 not disclosed
Fiscal years on record
8
Quarters on record
0
Revenue change, latest year
against the preceding fiscal year
Revenue growth run
0 yr
consecutive years higher than the previous
Years with income above zero
0
7 years below zero on record
Revenue rank in peer group
by latest annual revenue
Disclosure lag
68 d
period end to filing date
Latest period end
2025-12-31
filed 2026-03-09
Periods that do not reconcile
0
four quarters against the reported year

Explainable annual analytics

latest annual period where both published inputs exist
Ratios are arithmetic over reported SEC facts, not ratings, forecasts or investment advice.
MetricValueFiscal yearInputsSource tags
Return on assets-40.3%FY2025Net income: -$42.6MTotal assets: $105.7MNetIncomeLoss / Assets
Return on equity-55.3%FY2025Net income: -$42.6MShareholders equity: $77.1MNetIncomeLoss / StockholdersEquity
Liabilities / assets27.0%FY2025Total liabilities: $28.6MTotal assets: $105.7MLiabilities / Assets
Cash / assets11.5%FY2025Cash and equivalents: $12.2MTotal assets: $105.7MCashAndCashEquivalentsAtCarryingValue / Assets

Not computed: Gross margin — both metrics are not available for a common annual period; Operating margin — both metrics are not available for a common annual period; Net margin — both metrics are not available for a common annual period; Operating cash-flow margin — both metrics are not available for a common annual period.

Mapping completeness

10 of 12

10 of 12 canonical metrics were filled from this company's filings through the explicit tag map. Tags outside that map are recorded and counted, and are never used as a value.

Not on record for this company: Revenue, Gross profit. This means the figure was not disclosed in a form we accept, not that it is zero.

Annual figures

8 fiscal years shown
Metric20252024202320222021202020192018
Operating income-$42.3M-$36M-$35.7M-$32.1M$13.8M-$9.2M$8M
Net income-$42.6M-$31.8M-$29.2M-$33.8M-$27.3M-$8.9M-$8.4M
Operating cash flow-$26.7M-$19.8M-$18M-$23.9M-$11.8M-$7.3M-$6.9M
Total assets$105.7M$86.2M$107.4M$120.1M$42.2M$53M
Total liabilities$28.6M$23.5M$22.9M$14.5M$23M$7.5M
Shareholders equity$77.1M$62.7M$84.5M$105.7M-$34.8M-$8.4M-$193K$1.9M
Cash and equivalents$12.2M$13.7M$12.7M$5.8M$23.2M$15.6M
Shares outstanding88,009,73770,380,57069,670,61269,105,00040,528,91340,433,578
EPS, basic-$0.53-$0.45-$0.42-$0.53-$0.67-$0.22-$0.25
EPS, diluted-$0.53-$0.45-$0.42-$0.53-$0.67-$0.22-$0.25

Quarterly figures

0 fiscal quarters shown

No quarterly figures on record

Quarterly figures come from Form 10-Q. Foreign private issuers filing on Form 20-F do not file them.

Latest figure against the peer median

all 722 companies with figures on record
An industry classification is not on record for this company, so the comparison group is every company whose figures we hold, across all sectors. The median is stated with the group it was computed over; it is a fact about that group and nothing more.
MetricLatest annual figurePeer medianDifferenceCompanies in groupSource tag
Operating income · FY2025-$42.3M-$3.8M 1,014.3%591OperatingIncomeLoss
Net income · FY2025-$42.6M$2.4M 1,842.1%716NetIncomeLoss
Operating cash flow · FY2025-$26.7M$20.1M 232.6%715NetCashProvidedByUsedInOperatingActivities
Total assets · FY2025$105.7M$1.1B 90.5%720Assets
Total liabilities · FY2025$28.6M$458.2M 93.8%664Liabilities
Shareholders equity · FY2025$77.1M$301M 74.4%716StockholdersEquity
Cash and equivalents · FY2025$12.2M$82.6M 85.2%688CashAndCashEquivalentsAtCarryingValue
Shares outstanding · FY202588,009,73749,628,137 +77.3%606CommonStockSharesOutstanding
EPS, basic · FY2025-$0.53$0.05 1,160.0%678EarningsPerShareBasic
EPS, diluted · FY2025-$0.53$0.03 2,220.0%678EarningsPerShareDiluted

Where the numbers come from

every figure traces to a filing
MetricFiscal periodPeriod endFiledFormAccessionXBRL tag
Operating incomeFY20252025-12-312026-03-0920-F0001213900-26-025174OperatingIncomeLoss
Net incomeFY20252025-12-312026-03-0920-F0001213900-26-025174NetIncomeLoss
Operating cash flowFY20252025-12-312026-03-0920-F0001213900-26-025174NetCashProvidedByUsedInOperatingActivities
Total assetsFY20252025-12-312026-03-0920-F0001213900-26-025174Assets
Total liabilitiesFY20252025-12-312026-03-0920-F0001213900-26-025174Liabilities
Shareholders equityFY20252025-12-312026-03-0920-F0001213900-26-025174StockholdersEquity
Cash and equivalentsFY20252025-12-312026-03-0920-F0001213900-26-025174CashAndCashEquivalentsAtCarryingValue
Shares outstandingFY20252025-12-312026-03-0920-F0001213900-26-025174CommonStockSharesOutstanding
EPS, basicFY20252025-12-312026-03-0920-F0001213900-26-025174EarningsPerShareBasic
EPS, dilutedFY20252025-12-312026-03-0920-F0001213900-26-025174EarningsPerShareDiluted

Source: U.S. Securities and Exchange Commission, EDGAR company facts · as of 2026-03-09

Alpha Tau Medical Ltd. financial figures — 8 fiscal years on record — Tapewire